PCM Scientific has launched a new RCN accredited module ‘Multiple Myeloma and Proteasome Inhibitors’, on the Oncology Nursing in Practice platform.

The module aims to educate nurses on multiple myeloma and the therapies used in its treatment, with a focus on proteasome inhibitor therapies.

Over 17,000 people in the UK are diagnosed with this rare form of blood cancer. As multiple myeloma is incurable, nurses treating these patients play a vital role in supporting patients through their treatments and cancer journey.